Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: Current research support and recommendations for practitioners

Current Psychiatry Reports

Volumn 13, Issue 5, 2011, Pages 323-332

  Hurt, Elizabeth A ^a   Arnold, L Eugene ^a   Lofthouse, Nicholas ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

ADHD; Complementary and alternative medicine; Dietary treatments; Nutritional treatments; Recommendations

Indexed keywords

CARNITINE; DEANOL; ESSENTIAL FATTY ACID; HERBACEOUS AGENT; HOMEOPATHIC AGENT; MAGNESIUM; METHYLPHENIDATE; PLACEBO; TRACE ELEMENT; ZINC;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL EFFECTIVENESS; DIET RESTRICTION; DIET SUPPLEMENTATION; HOMEOPATHY; HUMAN; IRON THERAPY; PATIENT IDENTIFICATION; PATIENT SAFETY; PATIENT SELECTION; RISK BENEFIT ANALYSIS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

AMINO ACIDS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DIETARY SUPPLEMENTS; HOMEOPATHY; HUMANS; MINERALS; PRACTICE GUIDELINES AS TOPIC;

EID: 80755153026     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-011-0217-z     Document Type: Article

References (71)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (revised 4th ed.). Washington: American Psychiatric Association; 2000.
2. Kutcher S, Aman M, Brooks SJ, et al. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behavior disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol. 2004;14:11-28. (Pubitemid 37495027)
3. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40:168-79. (Pubitemid 32111020)
4. National Center for Complementary and Alternative Medicine Publication No. D347 (2007). What is CAM? Available at http://nccam.nih.gov/health/ whatiscam/overview.htm. Accessed November 2010.
5. Kemper KJ, O'Connor KG. Pediatricians' recommendations for complementary and alternative medical (CAM) therapies. Ambul Pediatr. 2004;4:482-7. (Pubitemid 39600039)
6. •• Arnold LE, Hurt EA, Mayes T, Lofthouse N. Ingestible alternative and complementary treatments for attention-deficit/hyperactivity disorder. In: Hoza B, Evans, SW, editors. Treating attention-deficit disorder. Kingston: Civic Research Institute; 2011. This chapter provides an evaluation of the current research support for ingestible CAM treatments of pediatric ADHD.
7. Chan E, Rappaport LA, Kemper KJ. Complementary and alternative therapies in childhood attention and hyperactivity problems. J Dev Behav Pediatr. 2003;24:4-8. (Pubitemid 36305475)
8. Benton D, Roberts G. Effect of vitamin and mineral SUPPL.ementation on intelligence of a sample of schoolchildren. Lancet. 1988;331:140-3. (Pubitemid 18027994)
9. Benton D, Cook R. Vitamin and mineral SUPPL.ements improve the intelligence scores and concentration of six-year-old children. Personal Individ Differ. 1991;12:1151-8.
10. Crombie IK, Flory C, Todman J, et al. Effect of vitamin and mineral SUPPL.ementation on verbal and nonverbal reasoning of schoolchildren. Lancet. 1990;335:744-7. (Pubitemid 20106680)
11. Benton D, Buts JP. Vitamin/mineral SUPPL.ementation and intelligence. Lancet. 1990;335:1158-60. (Pubitemid 20159458)
12. McCann D, Barrett A, Cooper A, et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blind, placebo-controlled trial. Lancet. 2007;370:1560-7. (Pubitemid 350018874)
13. Stevens LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr. 1995;62:761-8.
14. Spahis S, Vanasse M, Belanger SA, et al. Lipid profile, fatty acid composition and pro-and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2008;79:47-53.
15. Brookes KJ, Chen W, Xu X, et al. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;60:1053-61. (Pubitemid 44647221)
16. Belanger SA, Vanasse M, Spahis S, et al. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled study. Paediatr Child Health. 2009;14:89-98.
17. Gustafsson PA, Birberg-Thornberg U, Duchen K, et al. EPA SUPPL.ementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr. 2010;99:1540-9.
18. Arnold LE, Kleykamp D, Votolato NA, et al. Gamma-linolenic acid for attention-deficit/hyperactivity disorder: placebo-controlled comparison to D-amphetamine. Biol Psychiatry. 1989;25:222-8. (Pubitemid 19034959)
19. Calarge C, Farmer C, DiSilvestro R, Arnold LE. Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2010;20:495-502.
20. Oner P, Oner O. Relationship of ferritin to symptom ratings children with attention deficit hyperactivity disorder: effect of comorbidity. Child Psychiatry Hum Dev. 2008;39:323-30.
21. Sever Y, Ashkenazi A, Tyano S, Weizman A. Iron treatment in children with attention-deficit/hyperactivity disorder: a preliminary report. Neuropsychobiology. 1997;35:178-80. (Pubitemid 27212154)
22. Konofal E, Lecendreux M, Deron J, et al. Effects of iron SUPPL.ementation on attention deficit hyperactivity disorder in children. Pediatr Neurol. 2008;38:20-6. (Pubitemid 350181289)
23. Conners CK. Food additives and hyperactive children. London: Plenum; 1980.
24. National Institutes of Health. NIH consensus development conference: defined diets and childhood hyperactivity. Clin Pediatr. 1982;21:627-30.
25. US Food and Drug Administration: http://www.fda.gov/AdvisoryCommittees/ CommitteesMeetingMaterials/FoodAdvisoryCommittee/ucm1 49740.htm.
26. Pelsser LM, Frankena K, Toorman J, et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet. 2011;377:494-503.
27. Bateman B, Warner JO, Hutchinson E, et al. The effects of a double blind, placebo controlled artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children. Arch Dis Child. 2004;89:506-11.
28. Van Oudheusden LJ, Scholte HR. Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2002;67:33-8. (Pubitemid 35222838)
29. Arnold LE, Amato A, Bozzolo H, et al. Acetyl-L-Carnitine in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol. 2007;17:791-801. (Pubitemid 351158604)
30. Abbasi SH, Heidari S, Mohammadi MR, et al. Acetyl-l-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a placebocontrolled trial. Child Psychiatry Hum Dev 2011, published online ahead of print.
31. Ferrari R, Merli E, Ciccitelli G, et al. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N YAcad Sci. 2004;1033:79-91. (Pubitemid 39656740)
32. Re O. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Curr Therap Res Clin Exp. 1974;16:1238-42.
33. Lewis JA, Young R. Deanol and methylphenidate in minimal brain dysfunction. Int J Clin Pharmacol Ther. 1975;17:534-40.
34. Arnold LE, Votolato NA, Kleykamp D, et al. Does hair zinc predict amphetamine improvement of ADHD/hyperactivity? Int J Neurosci. 1990;50:103-7.
35. Bilici M, Yildirim F, Kandil S, et al. Double-blind, placebocontrolled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:181-90. (Pubitemid 37548510)
36. Uckardes Y, Ozmert EN, Unal F, Yurdakok K. Effects of zinc SUPPL.ementation on parent and teacher behavior rating scores in low socioeconomic level Turkish primary school children. Acta Paediatri. 2009;98:731-6.
37. Akhondzadeh S, Mohammadi M, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. BMC Psychiatry. 2004;4.
38. • Arnold LE, DiSilvestro RA, Bozzolo D, et al. Zinc for attentiondeficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. J Child Adolesc Psychopharmacol 2011;21:1-19. This article is one of the few studies to evaluate CAM treatments as complementary treatments to standard stimulant medication.
39. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. Deficiency of certain trace elements in children with hyperactivity. Psychiatria Polska. 1994;28:345-53. (Pubitemid 24234918)
40. Mousain-Bosc M, Roche M, Poige A, et al. Improvements of neurobehavioral disorders in children SUPPL.emented with magnesium-vitamin B6. Magnes Res. 2006;19:46-52. (Pubitemid 43945610)
41. Mousain-Bosc M, Roche M, Rapin J, Bali JP. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr. 2004;23:545S-8S.
42. Nogovitsina OR, Levitina EV. Neurological aspects of the clinical features, pathophysiology, and corrections of impairments in attention deficit hyperactivity disorder. Neurosci Biol Psychiatry. 2007;37:199-202. (Pubitemid 46453519)
43. Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological SUPPL.ementation on hyperactivity in children with attention-deficit/ hyperactivity disorder (ADHD): positive response to magnesium oral loading test. Magnes Res. 1997;10:149-56. (Pubitemid 127524359)
44. Izenwasser SE, Garcia-Valdez K, Kantak KM. Stimulant-like effects of magnesium on aggression in mice. Pharmacol Biochem Behav 1986;25:1195-9. (Pubitemid 17212800)
45. Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994;7:313-28.
46. Dykman KD, Dykman RA. Effect of nutritional SUPPL.ements on attentional-deficit hyperactivity disorder. Integr Physiol Behav Sci. 1998;33:49-60. (Pubitemid 128533675)
47. Dykman KD, McKinley R. Effect of Glyconutritionals on the severity of ADHD. Proc Fish Inst Med Res. 1997;1:24-5.
48. Kaplan BJ, Fisher JE, Crawford SG, et al. Improved mood and behavior during treatment with a mineral-vitamin SUPPL.ement: an open-label case series of children. J Child Adolesc Psychopharmacol. 2004;14:115-22. (Pubitemid 38525960)
49. • Rucklidge J, Taylor M, Whitehead K. Effect of micronutrients on behavior and mood in adults with ADHD: evidence from an 8-week open label trial with natural extension. J Attent Disord 2011;15:79-91. This article is one of the few studies to evaluate CAM treatments for adults with ADHD.
50. Harding KL, Judah RD, Gant CE. Outcome-based comparison of Ritalin versus food-SUPPL.ement treated children with ADHD. Altern Med Rev. 2003;8:319-30. (Pubitemid 37099890)
51. Krummel DA, Seligson FH, Guthrie HA. Hyperactivity: is candy causal? Crit Rev Food Sci Nutr. 1996;36:31-47.
52. Wolraich ML, Lindgren SD, Stumbo PJ, et al. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. N Engl J Med. 1994;330:301-7. (Pubitemid 24041373)
53. Wesnes KA, Pincock C, Richardson D, et al. Breakfast reduces declines in attention and memory over the morning in schoolchildren. Appetite. 2003;41:329-31. (Pubitemid 37444076)
54. Bornstein RA, Baker GB, Carroll A, et al. Plasma amino acids in attention deficit disorder. Psychiatry Res. 1990;33:301-6. (Pubitemid 20299764)
55. Stein TP, Sammaritano AM. Nitrogen metabolism in normal and hyperkinetic boys. Am J Clin Nutr. 1984;39:520-4. (Pubitemid 14135363)
56. Nemzer E, Arnold LE, Votolato NA, McConnell H. Amino Acid SUPPL.ementation as therapy for attention deficit disorder (ADD). J Am Acad Child Adolesc Psychiatry. 1986;25:509-13. (Pubitemid 16089396)
57. Zametkin AJ, Karoum F, Rapoport J. Treatment of hyperactive children with d-phenylalanine. Am J Psychiatry. 1987;144:792-4. (Pubitemid 17086863)
58. Arnold LE, Christopher J, Huestis RD, Smeltzer DJ. Megavitamins for minimal brain dysfunction: a placebo-controlled study. JAMA. 1978;240:2642-3. (Pubitemid 9100749)
59. Brenner A. The effects of megadoses of selected B complex vitamins on children with hyperkinesis; controlled studies with long-term follow-up. J Learn Disabil. 1982;15:258-64.
60. Canadian Paediatric Society. Megavitamin and megamineral therapy in childhood. Can Med Assoc J. 1990;143:1009-113.
61. McGuire JK, Kulkarni MS, Baden HP. Fatal hypermagnesemia in a child treated with megavitamin/megamineral therapy. Pediatrics. 2000;105:E18.
62. Trebaticka J, Kopasova S, Hradecna Z, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. Eur Child Adolesc Psychiatry. 2006;15:329-35. (Pubitemid 44306140)
63. Tenenbaum S, Paull JC, Sparrow EP, et al. An experimental comparison of Pycnogenol and methylphenidate in adults with attention-deficit/hyperactivity disorder (ADHD). J Atten Disord. 2002;6:49-60.
64. Weber W, Stoep AV, McCarty RL, et al. Hypericum perforatum (St John's Wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA. 2008;299:2633-41. (Pubitemid 351831593)
65. Salehi B, Imani R, Mohammadi MR, et al. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:76-80.
66. Lyon MR, Cline JC, De Zepetnek JT, et al. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study. J Psychiatry Neurosci. 2001;26:221-8. (Pubitemid 32552178)
67. Katz M, Levine AA, Kol-Degani H, Kav-Venaki L. A compound herbal preparation (CHP) in the treatment of children with ADHD: a randomized controlled trial. J Atten Disord. 2010;14:281-91.
68. Lamont J. Homeopathic treatment of attention deficit hyperactivity disorder. Br Homeopath J. 1997;86:196-200.
69. Frei H, Everts R, von Ammon K, et al. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. Eur J Pediatr. 2005;164:758-67. (Pubitemid 41609477)
70. Strauss LC. The efficacy of a homeopathic preparation in the management of attention deficit hyperactivity disorder. J Biomed Ther. 2000;18:197-201.
71. Jacobs J, Williams AL, Girard C, et al. Homeopathy for attentiondeficit/hyperactivity disorder: a pilot randomized-controlled trial. J Altern Complement Med. 2005;11:799-806. (Pubitemid 41739353)